Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

545.00
+3.380.62%
Post-market: 545.000.00000.00%16:15 EDT
Volume:986.17K
Turnover:540.23M
Market Cap:23.38B
PE:19.50
High:558.30
Open:542.41
Low:541.90
Close:541.62
52wk High:609.35
52wk Low:409.07
Shares:42.89M
Float Shares:39.35M
Volume Ratio:0.60
T/O Rate:2.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.65
PE(LYR):19.56

Loading ...

Liquidia ruling has positive read-through for MannKind Tyvaso DPI, says Truist

TIPRANKS
·
Oct 01

United Therapeutics Gets Legal Win in Patent Litigation Against Liquidia

Dow Jones
·
Oct 01

United Therapeutics Shares up 12.2% After Co Wins Court Ruling Against Liquidia

THOMSON REUTERS
·
Oct 01

Judge upholds claims 1, 14 of United Therapeutics’ ‘327 patent

TIPRANKS
·
Oct 01

United Therapeutics Corp Stock (UTHR) Moved Up by 12.20% on Sep 30: Key Drivers Unveiled

TradingKey
·
Oct 01

United Therapeutics up 13% to $543.85 following Liquidia patent ruling

TIPRANKS
·
Oct 01

United Therapeutics rises 13.2%

TIPRANKS
·
Oct 01

Movement Alert|United Therapeutics Rises 11.53% in Regular Trading, Multiple Catalysts Including FDA Filings and Share Buyback Drive Largest Gain Since March

Market Focus
·
Sep 30

United Therapeutics Chairperson, CEO Martine Rothblatt Reports UTHR Common Share Disposal Worth $4.61 Million

Reuters
·
Sep 29

United Therapeutics Downgraded to Sell as Premium Valuation Clashes with Shrinking Core Business and Challenging Launch Outlook for Tyvaso and Jenraldi

TIPRANKS
·
Sep 25

United Therapeutics Chairperson, CEO Martine A. Rothblatt Reports Disposal of Common Shares Worth $4.4 Million

Reuters
·
Sep 25

United Therapeutics initiated with a Sell at Goldman Sachs

TIPRANKS
·
Sep 24

United Therapeutics Chairperson and CEO Martine A. Rothblatt Disposes of 9,500 Common Shares Worth $4.69 Million

Reuters
·
Sep 23

United Therapeutics EVP, General Counsel Paul A. Mahon Disposes of USD 4.12 Million in Common Shares

Reuters
·
Sep 19

United Therapeutics CEO Martine A. Rothblatt Disposes of 9,500 Shares Worth USD 4.76 Million

Reuters
·
Sep 17

Bellevue Flags US Healthcare Innovation as Driving Fresh Investment Opportunities

Reuters
·
Sep 14

United Therapeutics CEO Martine A. Rothblatt Disposes of USD 3.94 Million in Common Shares

Reuters
·
Sep 11

United Therapeutics Announces New Accelerated Share Repurchase

TIPRANKS
·
Sep 09

United Therapeutics CEO Martine Rothblatt Disposes of Common Shares Worth $4.64 Million

Reuters
·
Sep 09

United Therapeutics to Repurchase $478 Million of Shares

MT Newswires Live
·
Sep 08